Single-blinded controlled trial of low-dose oral IFN-α for the treatment of xerostomia in patients with Sjogren's syndrome

Journal of Interferon and Cytokine Research

Volumn 18, Issue 4, 1998, Pages 255-262

  Shiozawa, Shunichi ^a,b   Tanaka, Yasushi ^a   Shiozawa, Kazuko ^a  

^a KOBE UNIVERSITY HOSPITAL   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; SUCRALFATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LYMPHOCYTIC INFILTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALIVARY GLAND; SALIVATION; SINGLE BLIND PROCEDURE; SJOEGREN SYNDROME; TREATMENT OUTCOME; XEROSTOMIA;

EID: 0031900178     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1998.18.255     Document Type: Article

References (48)

1. FOX, R.I., HOWELL, F.V., BONE, R.C., and MICHELSON, P. (1984). primary Sjögren's syndrome with clinical immunologic features. Semin. Arthritis. Rheu. 14, 77-105.
2. ST. CLAIR, E.W. (1993). New developments in Sjögren's syndrome. Curr. Opin. Rheumatol. 5, 604-612.
3. TALAL, N. (1993). Sjögren's syndrome and connective tissue diseases associated with other immunologic disorders. In: Arthritis and Allied Conditions, 12th ed. D.J. McCarty and W.J. Koopman (eds.) Philadelphia: Lea & Febiger, pp. 1343-1356.
4. FOX, P.C., and SEIGHT, P.M. (1996). Current concepts of autoimmune exocrinopathy: immunogenic mechanisms in the salivary pathology of Sjögren's syndrome. Crit. Rev. Oral. Biol. Med. 7, 144-158.
5. PRICE, V.J., and VENABLES, P.F.W. (1995). The etiopathogenesis of Sjögren's syndrome. Semin. Arthritis. Rheu. 25, 117-133.
6. FOX, R.I., KANG, H., ANDO, D., ABRAHAMS, J., and PISA, E. (1994). Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J. Immunol. 152, 5532-5539.
7. MCCARTHY-FRANCIS, N.L., MIZEL, D.E., REDMAN, R.S., FRAZIER-JESSEN, M., PANEK, R.B., KULKARNI, A.B., WARD, J.M., McCARTHY, J.B., and WAHL, S.M. (1996). Autoimmune Sjögren's-like lesions in salivary glands of TGF-β-1 deficient mice are inhibited by adhesion-blocking peptides. J. Immunol. 157, 1306-1312.
8. OGAWA, N., DANG, H., LAZARIDIS, K., McGUFF, H.S., AUFDEMORTE, T.B., and TALAL, N. (1995). Analysis of transforming growth factor B and other cytokines in autoimmune exocrinopathy (Sjögren's syndrome). J. Interferon Cytokine Res. 15, 759-767.
9. ATKINSON, J.C., ROYCE, L.S., WELLNER, R., PILLEMER, S.R., BERMUDEZ, D., and FOX, P.C. (1995). Anti-salivary antibodies in primary Sjögren's syndrome. J. Oral Pathol. Med. 24, 206-212.
10. HANEJI, N., NAKAMURA, T., TAKIA, K., YANAGI, K., HIGASHIYAMA, H., SAITO, I., NOJI, S., SUGINO, H., and HAYASHI, Y. (1997). Identification of α-fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science 276, 604-607.
11. GOTO, M., TANIMOTO, K., CHIHARA, T., and HORIUCHI, Y. (1981). Natural cell-mediated cytotoxicity in Sjögren's syndrome and rheumatoid arthritis. Arthritis Rheum. 24, 1377-1382.
12. MINATO, N., TAKEDA, A., KANO, S., and TAKAKU, F. (1982). Studies of the functions of natural killer-interferon system in patients with Sjögren's syndrome. J. Clin. Invest. 69, 581-588.
13. MIYASAKA, N., SEAMAN, W., BAKSHI, A., SAUVEZIE, B., STRAND, V., POPE, R., and TALAL, N. (1983). Natural killing activity in Sjögren's syndrome. An analysis of defective mechanism. Arthritis Rheum. 26, 954-960.
14. SHIOZAWA, S., MORIMOTO, I., TANAKA, Y., and SHIOZAWA, K. (1993). A preliminary study on the interferon-α treatment for xerostomia of Sjögren's syndrome. Br. J. Rheum. 32, 52-54.
15. FERRACCIOLI, G.F., SALAFFI, F., DE VITA, S., CASATTA, L., AVELLINI, C., CAROTTI, M., BELTRAMI, C.A., CERVINI, C., and BARTOLI, E. (1996). Interferon alpha-2 (IFNα2) increases lacrimal and salivary function in Sjögren's syndrome patients. Preliminary results of an open pilot trial versus OH-chloroquine. Clin. Exp. Rheumatol. 14, 367-371.
16. SHIOZAWA, S., KUROKI, Y., YOSHIHARA, R., CHIHARA, K., HIRATA, M., TANAKA, Y., and SHIOZAWA, K. (1993). Increasing effect of oral interferon effect of oral interferon α(IFNα) in saliva secretion of Sjögren's syndrome patients. Abstracts of the 37th Annual Meeting, Japan Rheumatology Association, May 23, 1993.
17. SHIOZAWA, K., TANAKA, Y., YOSHIHARA, R., HIRATA, M., KABEBUMA, S., and SHIOZAWA, S. (1994). Effect of orally administered interferon alpha (IFNα) on saliva production in Sjögren's syndrome. Abstract of the 38th Annual Meeting, Japan Rheumatology Association, April 29, 1994.
18. KOHLER, P., and WINTER, M. (1985). A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test. Arthritis Rheum. 28, 1128-1132.
19. SHIOZAWA, S., SHIOZAWA, K., SHIMIZU, S., TANAKA, Y., MORIMOTO, I., YOSHIHARA, R., KUROKI, Y., HASHIMOTO, M., and FUJITA, T. (1990). Immunoreactive circulating alpha-interferon is low in Sjögren's syndrome. Br. J. Rheumatol. 29, 50-52.
20. ROWE, D., GRIFFITHS, M., STEWART, J., NOVICK, D., BEVERLEY, P.C.L., and ISENBERG, D.A. (1987). HLA class I and II, interferon, interleukin-2, and the interleukin-2 receptor expression on labial biopsy specimens from patients with Sjögren's syndrome. Ann. Rheum. Dis. 46, 580-586.
21. SHIOZAWA, S., YOSHIKAWA, N., IIJIMA, K., and NEGISHI, K. (1988). A sensitive radioimmunoassay for circulating α-interferon in the plasma of healthy children and patients with measles virus infection. Clin. Exp. Immunol. 73, 366-369.
22. SHIOZAWA, S., CHIHARA, K., SHIOZAWA, K., FUJITA, T., IKEGAMI, H., KOYAMA, S., and KURIMOTO, M. (1986). A sensitive radioimmunoassay for alpha-interferon: circulating α-interferon-like substance in the plasma of healthy individuals and rheumatoid arthritis patients. Clin. Exp. Immunol. 66, 77-87.
23. SHIOZAWA, S., TANAKA, Y., MORIMOTO, I., MIYAUCHI, A., YAMATANI, T., and FUJITA, T. (1989). Radioimmunoassay of circulating alpha-interferon with reference to aging and osteoporosis. Gerontology 35, 305-310.
24. SAIGO, K., SHIOZAWA, S., SHIOZAWA, K., YAKUYA, J., UEDA, K., YAMAGUCHI, N., SHIBATA, H., and MASAOKA, T. (1988). Alpha-interferon treatment for adult T cell leukemia: low levels of circulating alpha-interferon and its clinical effectiveness. Blut 56, 83-86.
25. SHIOZAWA, S., KUROKI, Y., KIM, M., HIROHATA, S., and OGINO, T. (1992). Interferon-alpha in lupus psychosis. Arthritis Rheum. 35, 417-122.
26. DALTON, D.K., PITTS-MEEK, S., KESHAV, S., FIGARI, I.S., BRADLEY, A., and STEWART, T.A. (1993). Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259, 1739-1742.
27. HUANG, S., HEDRIKS, W., ALTHAGE, A., HEMMI, S., BLUETHMANN, H., KAMIJO, R., VILCEK, J., ZINKERNAGEL, R.M., and AGUET, M. (1993). Immune response in mice that lack the interferon-γ receptor. Science 259, 1742-1745.
28. TARGAN, S., and DOREY, F. (1980). Dual mechanism of interferon augmentation of natural killer cytotoxicity (NKCC). Ann. NY Acad. Sci. 350, 121-129.
29. PERUSSIA, B., and TRINCHIERI, G. (1981). Inactivation of natural killer cell cytotoxic activity after interaction with target cells. J. Immunol. 126, 754-758.
30. SHIOZAWA, S., SHIOZAWA, K., SHIMIZU, S., NAKADA, M., ISOBE, T., and FUJITA, T. (1987). Clinical studies of renal disease in Sjögren's syndrome. Ann. Rheum. Dis. 46, 768-772.
31. AGRESTI, S. (1990). Categorical Data Analysis. New York: John Wiley & Sons.
32. StatXact3 for Windows. Cambridge, MA: Cytel Software Corporation.
33. CHISHOLM, D.M., and MASON, D.K. (1968). Labial salivary gland biopsy in Sjögren's syndrome. J. Clin. Pathol. 21, 656-660.
34. SCHINDLER, R., GHEZZI, P., and DINARELLO, C.A. (1990). IL-1 induces IL-1. IV. IFN-gamma suppresses IL-1 but not lipopolysaccharide-induced transcription of IL-1. J. Immunol. 144, 2216-2222.
35. AMAN, M.J., KELLER, U., DERIGS, G., MOHAMADZADEH, M., HUBER, C., and PESCHEL, C. (1994). Regulation of cytokine expression by interferon alpha in human bone marrow stromal cells: inhibition of hematopoietic growth factors and induction of IL-1 receptor antagonist. Blood 84, 4142-4150.
36. JEWETT, A., and BONAVIDA, B. (1995). Interferon-alpha activates cytotoxic function but inhibits interleukin-2-mediated proliferation and tumor necrosis factor-alpha secretion by immature human natural killer cells. J. Clin. Immunol. 15, 35-44.
37. CSANAKY, G., VASS, J.A., OCSOVSZKI, I., MILOSEVITS, J., SZOMOR, A., and SCHMELCZER, M. (1995). Changes in adhesion molecule expression and function in B-cell chronic lymphocytic leukemia after in vitro interferon-alpha stimulation. Eur. J. Haematol. 54, 27-33.
38. + T cells and monocytes. Blood 87, 4731-4736.
39. BROD, S.A., and KHAN, M. (1996). Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis. J. Autoimmunity 9, 11-20.
40. + hepatitis patients with lose dose natural human interferon alpha administered orally. Arch. Immunol. Ther. Exp. 41, 241-251.
41. HUTCHINSON, V.A., ANGEHEND, J.L., MOK, W.L., CUMMINS, J.M., and RICHARDS, A.B. (1990). Chronic recurrent aphthous stomatitis: oral treatment with low-dose interferon alpha. Mol. Biother. 2, 160-164.
42. YOUNG, A.S., MARITIM, A.C., KARIUKI, D.P., STAGG, D.A., WAFULA, J.M., MUTUGI, J.J., CUMMINS, J.M., RICHARDS, A.B., and BURNS, C. (1990). Low-dose oral administration of human interferon alpha can control the development of Theileria parva infection in cattle. Parasitology 101, 201-209.
43. CUMMINS, J.M., HUTCHESON, D.P., CUMMINGS, M.J., GEORGIADES, J.A., and RICHARDS, A.B. (1993). Oral therapy with human interferon alpha in calves experimentally injected with infectious bovine rhinotracheitis virus. Arch. Immunol. Ther. Exp. 41, 193-197.
44. CUMMINS, J.M., GAWTHROP, J., HUTCHESON, D.P., CUMMINS, M.J., and ZECK, D. (1993). The effect of low dose oral human interferon alpha therapy on diarrhea in veal calves. Arch. Immunol. Ther. Exp. 41, 199-203.
45. MOORE, B.R., KRAKOWKA, S., CUMMINS, J.M., and ROBERTSON, J.T. (1996). Changes in airway inflammatory cell populations in standard-bred racehorses after interferon-alpha administration. Vet. Immunol. Immunopathol. 49, 347-358.
46. CUMMINS, J.M., MOCK, R.E., SHIVE, B.W., KRAKOWKA, S., RICHARDS, A.B., and HUTCHESON, D.P. (1995). Oral treatment of transmissible gastroenteritis with natural human interferon alpha: a field study. Vet. Immunol. Immunopathol. 45, 355-360.
47. CUMMINS, J.M., TOMPKINS, M.B., OLSEN, R.G., TOMPKINS, W.A., and LEWIS, M.G. (1988). Oral use of human alpha interferon in cats. J. Biol. Response Mod. 7, 513-523.
48. STANTON, G.J., LLOYD, R.E., SARZOTTI, M., and BLALOCK, J.E. (1989). Protection of mice from Semliki Forest virus infection by lymphocytes treated with low levels of interferon. Mol. Biother. 1, 305-310.